Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time
- PMID: 4861752
- DOI: 10.1097/00005053-196708000-00008
Paranoid and withdrawal symptoms in schizophrenia: differential symptom reduction over time
Similar articles
-
Differences in clinical effects of three phenothiazines in "acute" schizophrenia.Dis Nerv Syst. 1967 Jun;28(6):369-83. Dis Nerv Syst. 1967. PMID: 5342391 Clinical Trial. No abstract available.
-
Schizophrenic subtypes defined by response to drugs and placebo.Dis Nerv Syst. 1968 May;29(5):Suppl:153-8. Dis Nerv Syst. 1968. PMID: 4876985 Clinical Trial. No abstract available.
-
Prediction of improvement in schizophrenia under four phenothiazines.Arch Gen Psychiatry. 1967 Jan;16(1):107-17. doi: 10.1001/archpsyc.1967.01730190109015. Arch Gen Psychiatry. 1967. PMID: 6066689 Clinical Trial. No abstract available.
-
[Differential indication for the use of neuroleptics].Act Nerv Super (Praha). 1970 Jan 12;12(1):1-11. Act Nerv Super (Praha). 1970. PMID: 4907389 Review. Czech. No abstract available.
-
Drug treatment in schizophrenia.Can Psychiatr Assoc J. 1971 Dec;16(6):473-85. doi: 10.1177/070674377101600603. Can Psychiatr Assoc J. 1971. PMID: 4947634 Review. No abstract available.
Cited by
-
Maintenance treatment with antipsychotic drugs for schizophrenia.Cochrane Database Syst Rev. 2020 Aug 11;8(8):CD008016. doi: 10.1002/14651858.CD008016.pub3. Cochrane Database Syst Rev. 2020. PMID: 32840872 Free PMC article.
-
Cessation of medication for people with schizophrenia already stable on chlorpromazine.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD006329. doi: 10.1002/14651858.CD006329. Cochrane Database Syst Rev. 2007. PMID: 17253586 Free PMC article.
-
Performance tests in a study of phenothiazines in schizophrenia: caveats and conclusions.Psychopharmacologia. 1972;24(1):81-98. doi: 10.1007/BF00402906. Psychopharmacologia. 1972. PMID: 5062969 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources